Pegasys

Active ingredient
Peginterferon alfa 2a, Ribavirin, Boceprevir, Telaprevir
Medical indication
Hepatitis C
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
1,193 doctors
Total Number of Patients2
23,136 patients
Total minimum fees planned3
29,002,829.28 €

Observational Studies including Pegasys

Drug No. of doctors1 No. of patients2 Payment per patient3
Pegasys, Copegus, Victrelis, Incivo 15 58 540.30 € 11 Dokumentationen
Pegasys 473 9,790 1,762.68 € je 5 Dokumentationsbögen bei 12 Visiten
Pegasys 41 250 603.18 € Euro pro ordnungsgemäß durchgeführter Patientendokumentation (max. 10 Pat.)
Pegasys, Rebetol, Copegus, Pegintron 36 400 350.00 € pro Patientenbogen + 10 EUR für Screening
Pegasys 30 149 603.18 € pro ordnungsgemäß ausgefülltem und elektronisch übermitteltem Datensatz
Pegasys, Copegus 78 2,500 151.54 € pro ordnungsgemäß ausgefülltem und elektronisch übermitteltem Datensatz
Pegasys, Copegus 520 9,989 1,096.74 € max. pro Studie

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.